person · Reporting owner
Baudot-Trajtenberg Nadine
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cellebrite DI Ltd.CLBT · Entity 4238 | Director | September 17, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cellebrite DI Ltd.
Report date September 17, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary shares, par value NIS 0.00001SEC Table I · non-derivative | Direct | 50,744 |
Reported balance
After 2026-09-17 transaction · row 1
1 source rowRow 1 · 2026-09-17 · Grant · Acquired 15,190 · Balance 50,744 F1: Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2026 Filed Sep 17, 2026 12:05 UTC | Cellebrite DI Ltd. CLBT · Entity 4238 | GrantOrdinary shares, par value NIS 0.00001 | 15,190 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-062371 · wk-form4_1789646712.xml · nonDerivative · entry 1 Baudot-Trajtenberg Nadine · CIK 0001970941 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,744 F1 · shares: Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.